Stevens Capital Management LP Takes $594,000 Position in Merit Medical Systems, Inc. (MMSI)

Stevens Capital Management LP purchased a new stake in Merit Medical Systems, Inc. (NASDAQ:MMSI) in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 14,021 shares of the medical instruments supplier’s stock, valued at approximately $594,000.

A number of other hedge funds and other institutional investors have also modified their holdings of the business. Vanguard Group Inc. lifted its holdings in Merit Medical Systems by 4.5% in the 2nd quarter. Vanguard Group Inc. now owns 4,374,628 shares of the medical instruments supplier’s stock valued at $166,893,000 after acquiring an additional 187,745 shares during the last quarter. Frontier Capital Management Co. LLC lifted its stake in Merit Medical Systems by 24.8% during the second quarter. Frontier Capital Management Co. LLC now owns 2,737,303 shares of the medical instruments supplier’s stock valued at $104,428,000 after buying an additional 543,580 shares in the last quarter. Dimensional Fund Advisors LP lifted its stake in Merit Medical Systems by 0.7% during the second quarter. Dimensional Fund Advisors LP now owns 2,694,722 shares of the medical instruments supplier’s stock valued at $102,803,000 after buying an additional 19,257 shares in the last quarter. Janus Henderson Group PLC lifted its stake in Merit Medical Systems by 922.3% during the second quarter. Janus Henderson Group PLC now owns 1,533,513 shares of the medical instruments supplier’s stock valued at $58,504,000 after buying an additional 1,383,513 shares in the last quarter. Finally, State Street Corp lifted its stake in Merit Medical Systems by 9.9% during the second quarter. State Street Corp now owns 1,339,547 shares of the medical instruments supplier’s stock valued at $51,105,000 after buying an additional 120,759 shares in the last quarter. 89.52% of the stock is owned by institutional investors.

Merit Medical Systems, Inc. (MMSI) opened at $40.85 on Friday. The firm has a market capitalization of $1,867.40, a PE ratio of 29.29, a PEG ratio of 2.52 and a beta of 1.20. Merit Medical Systems, Inc. has a twelve month low of $22.80 and a twelve month high of $45.50. The company has a quick ratio of 1.43, a current ratio of 2.78 and a debt-to-equity ratio of 0.39.

Merit Medical Systems (NASDAQ:MMSI) last issued its earnings results on Wednesday, October 25th. The medical instruments supplier reported $0.32 earnings per share for the quarter, beating analysts’ consensus estimates of $0.30 by $0.02. The company had revenue of $179.30 million for the quarter, compared to the consensus estimate of $181.28 million. Merit Medical Systems had a return on equity of 9.86% and a net margin of 4.06%. The firm’s quarterly revenue was up 14.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.26 EPS. sell-side analysts forecast that Merit Medical Systems, Inc. will post 1.27 earnings per share for the current fiscal year.

A number of analysts have commented on the stock. Piper Jaffray Companies reaffirmed a “buy” rating and set a $45.00 price objective on shares of Merit Medical Systems in a research note on Friday, July 28th. Canaccord Genuity upped their price objective on shares of Merit Medical Systems from $45.00 to $47.50 and gave the company a “buy” rating in a research note on Thursday, October 26th. Zacks Investment Research lowered shares of Merit Medical Systems from a “buy” rating to a “hold” rating in a research note on Tuesday, October 3rd. Bank of America Corporation assumed coverage on shares of Merit Medical Systems in a research note on Thursday, July 20th. They set a “buy” rating and a $44.00 price objective for the company. Finally, Craig Hallum reaffirmed a “buy” rating and set a $50.00 price objective (up from $42.00) on shares of Merit Medical Systems in a research note on Thursday, July 27th. One analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company. Merit Medical Systems has an average rating of “Buy” and an average price target of $41.65.

COPYRIGHT VIOLATION WARNING: “Stevens Capital Management LP Takes $594,000 Position in Merit Medical Systems, Inc. (MMSI)” was first posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of United States and international trademark & copyright law. The legal version of this piece of content can be read at https://ledgergazette.com/2017/11/17/stevens-capital-management-lp-takes-594000-position-in-merit-medical-systems-inc-mmsi.html.

In other news, Director Kent W. Stanger sold 1,930 shares of the company’s stock in a transaction dated Monday, September 11th. The stock was sold at an average price of $42.02, for a total value of $81,098.60. The sale was disclosed in a filing with the SEC, which is accessible through this link. 5.00% of the stock is owned by corporate insiders.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

Institutional Ownership by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply